Strain identifier

BacDive ID: 2631

Type strain: Yes

Species: Clostridium perfringens

Strain Designation: S107

Strain history: ATCC 13124 <-- NCTC 8237 ("Clostridium welchii") <-- Wellcome Lab.; CN 1491.

NCBI tax ID(s): 195103 (strain), 1502 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 7 (current version):
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 7 (current version)

General

@ref: 428

BacDive-ID: 2631

DSM-Number: 756

keywords: toxin production, mesophilic, anaerobe, Bacteria, 16S sequence, genome sequence, human pathogen

description: Clostridium perfringens S107 is an anaerobe, mesophilic human pathogen that produces toxins and was isolated from bovine.

NCBI tax id

NCBI tax idMatching level
1502species
195103strain

strain history

doi: 10.13145/bacdive2631.20220920.7

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/bacillota
  • domain: Bacteria
  • phylum: Bacillota
  • class: Clostridia
  • order: Eubacteriales
  • family: Clostridiaceae
  • genus: Clostridium
  • species: Clostridium perfringens
  • full scientific name: Clostridium perfringens (Veillon and Zuber 1898) Hauduroy et al. 1937 (Approved Lists 1980)
  • synonyms

    • @ref: 20215
    • synonym: Bacillus perfringens

@ref: 428

domain: Bacteria

phylum: Firmicutes

class: Clostridia

order: Clostridiales

family: Clostridiaceae

genus: Clostridium

species: Clostridium perfringens

full scientific name: Clostridium perfringens (Veillon and Zuber 1898) Hauduroy et al. 1937

strain designation: S107

type strain: yes

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
428COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://bacmedia.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
428FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a)yeshttps://bacmedia.dsmz.de/medium/1203aName: FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a) Composition: Fastidious Anaerobe Basal Broth 35.4 g/l Distilled water
428CHOPPED MEAT MEDIUM WITH CARBOHYDRATES (DSMZ Medium 110)yeshttps://bacmedia.dsmz.de/medium/110Name: CHOPPED MEAT MEDIUM WITH CARBOHYDRATES (DSMZ Medium 110) Composition: Ground beef 500.0 g/l Casitone 30.0 g/l Agar 15.0 g/l K2HPO4 5.0 g/l Yeast extract 5.0 g/l D-Glucose 4.0 g/l Starch 1.0 g/l Maltose 1.0 g/l Cellobiose 1.0 g/l L-Cysteine HCl 0.5 g/l Ethanol 0.19 g/l Vitamin K3 0.05 g/l Hemin 0.005 g/l Sodium resazurin 0.0005 g/l NaOH Vitamin K1 Distilled water
42056MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)

culture temp

@refgrowthtypetemperaturerange
428positivegrowth37mesophilic
42056positivegrowth37mesophilic
44424positivegrowth37mesophilic
67770positivegrowth37mesophilic

Physiology and metabolism

oxygen tolerance

@refoxygen tolerance
428anaerobe
44424anaerobe

compound production

@refcompound
428haemolysins
428lecithinase
428lethal toxins
428phospholipase C
67770haemolysins
67770lethal toxins

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
6838027897tryptophan-energy source
6838017632nitrate+reduction
6838029985L-glutamate-degradation
6838016634raffinose+fermentation
6838016024D-mannose+fermentation
6838029016arginine+hydrolysis
6838016199urea-hydrolysis
6836727082trehalose+builds acid from
6836762345L-rhamnose-builds acid from
6836730911sorbitol-builds acid from
6836716634raffinose-builds acid from
683676731melezitose-builds acid from
6836716024D-mannose+builds acid from
6836717057cellobiose-builds acid from
683674853esculin+hydrolysis
683675291gelatin+hydrolysis
6836730849L-arabinose-builds acid from
6836765327D-xylose-builds acid from
6836717814salicin-builds acid from
6836717306maltose+builds acid from
6836717992sucrose+builds acid from
6836717716lactose+builds acid from
6836717634D-glucose+builds acid from
6836716199urea-hydrolysis
6836727897tryptophan-energy source

metabolite production

@refChebi-IDmetaboliteproduction
6838035581indoleno
6836735581indoleno

metabolite tests

@refChebi-IDmetaboliteindole test
6838035581indole-
6836735581indole-

enzymes

@refvalueactivityec
68380serine arylamidase-
68380glutamyl-glutamate arylamidase-
68380histidine arylamidase-
68380glycin arylamidase-
68380alanine arylamidase-3.4.11.2
68380tyrosine arylamidase-
68380pyrrolidonyl arylamidase+3.4.19.3
68380leucine arylamidase-3.4.11.1
68380phenylalanine arylamidase-
68380leucyl glycin arylamidase-3.4.11.1
68380proline-arylamidase-3.4.11.5
68380L-arginine arylamidase-
68380alkaline phosphatase+3.1.3.1
68380tryptophan deaminase-4.1.99.1
68380alpha-fucosidase+3.2.1.51
68380glutamate decarboxylase-4.1.1.15
68380N-acetyl-beta-glucosaminidase+3.2.1.52
68380beta-glucuronidase-3.2.1.31
68380alpha-arabinosidase-3.2.1.55
68380alpha-glucosidase+3.2.1.20
68380beta-galactosidase+3.2.1.23
68380alpha-galactosidase+3.2.1.22
68380arginine dihydrolase+3.5.3.6
68380urease-3.5.1.5
68367beta-glucosidase+3.2.1.21
68367gelatinase+
68367urease-3.5.1.5
67770phospholipase C3.1.4.11

API 20A

@refINDUREGLUMANLACSACMALSALXYLARAGELESCGLYCELMNEMLZRAFSORRHATRE
428--+-+++---++--+----+
428--++/-+++---+++-+----+

API rID32A

@refUREADH Argalpha GALbeta GALbeta GPalpha GLUbeta GLUalpha ARAbeta GURbeta NAGMNERAFGDCalpha FUCNITINDPALArgAProALGAPheALeuAPyrATyrAAlaAGlyAHisAGGASerA
428-+++-+---+++-++-+-----+------
428-++++++--+++-++-+-----+------

Isolation, sampling and environmental information

isolation

@refsample type
428bovine
44424Bovine
67770Bovine

isolation source categories

  • Cat1: #Host
  • Cat2: #Mammals
  • Cat3: #Bovinae (Cow, Cattle)

Safety information

risk assessment

  • @ref: 428
  • pathogenicity human: yes
  • pathogenicity animal: yes
  • biosafety level: 2
  • biosafety level comment: Risk group (German classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Clostridium perfringens gene for 16S rRNA, partial sequence, strain: ATCC 13124AB0757671460ena195103
20218Clostridium perfringens partial 16S rRNA gene, strain ATCC 13124FM207095390ena195103
20218Clostridium perfringens strain DSM 756 16S ribosomal RNA gene, partial sequenceHQ012013933ena1502
20218Clostridium perfringens 16S ribosomal RNAM591031462ena1502
20218{16S/23S ribosomal DNA spacer region} [Clostridium perfringens, ATCC 13124, Genomic, 239 nt]S51964239ena1502
67770Clostridium perfringens gene for 16S ribosomal RNA, partial sequence, strain: JCM 1290AB5737131474ena1502

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Clostridium perfringens ATCC 13124 ATCC 13124GCA_000013285completencbi195103
66792Clostridium perfringens ATCC 13124195103.10completepatric195103
66792Clostridium perfringens strain FDAARGOS_903 strain Not applicable1502.1789completepatric1502
66792Clostridium perfringens ATCC 13124637000077completeimg195103
67770Clostridium perfringens ATCC 13124, complete genomeCP000246ena195103

GC content

@refGC-contentmethod
42824.0
6777024thermal denaturation, midpoint method (Tm)

External links

@ref: 428

culture collection no.: DSM 756, ATCC 13124, ATCC 19408, NCIB 6125, NCTC 6125, NCTC 8237, WDCM 00007, CCUG 1795, CIP 103409, JCM 1290, BCRC 10913, CCM 4435, CECT 376, KCTC 3269, LMG 11264, NCIMB 6125

straininfo link

@refpassport
20218http://www.straininfo.net/strains/7948
20218http://www.straininfo.net/strains/7940
20218http://www.straininfo.net/strains/7941
20218http://www.straininfo.net/strains/7951
20218http://www.straininfo.net/strains/7952
20218http://www.straininfo.net/strains/7953
20218http://www.straininfo.net/strains/866259

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity10344Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D.Mollby R, Holme T, Nord CE, Smyth CJ, Wadstrom TJ Gen Microbiol10.1099/00221287-96-1-1371976Abdominal Injuries/microbiology, Clostridium Infections/microbiology, Clostridium perfringens/classification/growth & development/*metabolism, Feces/microbiology, Gas Gangrene/microbiology, Hemolysin Proteins/*biosynthesis, Humans, Hydrogen-Ion Concentration, Phospholipases/*biosynthesis, Serotyping, Species Specificity, Toxins, Biological/*biosynthesisPhylogeny
Cultivation518079Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.Sutter VL, Barry AL, Wilkins TD, Zabransky RJAntimicrob Agents Chemother10.1128/AAC.16.4.4951979Anaerobiosis, Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects, Culture Media, Evaluation Studies as Topic, Microbial Sensitivity Tests/*methodsPathogenicity
Enzymology1665065Collagenase of Clostridium perfringens type A: degradation of human complement component C1q.Wolf U, Bauer D, Traub WHZentralbl Bakteriol10.1016/s0934-8840(11)80215-x1991Blotting, Western, Clostridium perfringens/*enzymology, Complement C1q/*metabolism, Electrophoresis, Polyacrylamide Gel, Humans, Isoelectric Point, Microbial Collagenase/chemistry/isolation & purification/*metabolism, Molecular WeightMetabolism
Pathogenicity2280013Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CAJ Clin Microbiol10.1128/jcm.28.12.2804-2805.19901990Bacteria, Anaerobic/*drug effects, Meropenem, Microbial Sensitivity Tests/methods/*standards, Quality Control, Reference Values, Thienamycins/*pharmacology
Pathogenicity2643621Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RNJ Clin Microbiol10.1128/jcm.27.1.190-191.19891989Bacteria, Anaerobic/*drug effects, Cefotetan/*pharmacology, Microbial Sensitivity Tests/*standards, Multicenter Studies as Topic, Quality Control, Reference Values
Pathogenicity2882731Effect of antibiotics on toxin production and viability of Clostridium perfringens.Stevens DL, Maier KA, Mitten JEAntimicrob Agents Chemother10.1128/AAC.31.2.2131987Anti-Bacterial Agents/*pharmacology, Bacterial Toxins/*biosynthesis, *Calcium-Binding Proteins, Cefoxitin/pharmacology, Chloramphenicol/pharmacology, Clindamycin/pharmacology, Clostridium perfringens/*drug effects/growth & development/metabolism, Kinetics, Metronidazole/pharmacology, Microbial Sensitivity Tests, Penicillin G/pharmacology, Rifampin/pharmacology, Tetracycline/pharmacology, *Type C PhospholipasesEnzymology
Cultivation2886986Evaluation of some commercial media for the cultivation and enumeration of Clostridium perfringens from the chick intestine.Dafwang II, Ricke SC, Schaefer DM, Brotz PG, Sunde ML, Pringle DJPoult Sci10.3382/ps.06606521987Animals, Chickens/*microbiology, Clostridium perfringens/growth & development/*isolation & purification, Culture Media, Intestines/*microbiologyEnzymology
Cultivation2892327Growth curves of Clostridium perfringens in Schaedler and brain heart infusion broths.Traub WH, Spohr M, Bauer DZentralbl Bakteriol Mikrobiol Hyg A10.1016/s0176-6724(87)80035-41987Animals, Clostridium perfringens/*growth & development/pathogenicity, Culture Media, Humans, Mice, VirulencePathogenicity
Enzymology2903127Cloning and expression in Escherichia coli of the perfringolysin O (theta-toxin) gene from Clostridium perfringens and characterization of the gene product.Tweten RKInfect Immun10.1128/iai.56.12.3228-3234.19881988Amino Acid Sequence, Bacterial Toxins/*genetics/metabolism, Cloning, Molecular, Clostridium perfringens/*genetics, Escherichia coli/genetics/metabolism, Genes, Bacterial, Hemolysin Proteins, Hemolysis, Molecular Sequence Data, Molecular Weight, Peptide Mapping, Recombinant Proteins/genetics, Restriction MappingMetabolism
Enzymology3492177Inactivation of cefoxitin and moxalactam by Bacteroides bivius beta-lactamase.Malouin F, Fijalkowski C, Lamothe F, Lacroix JMAntimicrob Agents Chemother10.1128/AAC.30.5.7491986Bacteroides/*enzymology, Biological Assay, Cefoxitin/*antagonists & inhibitors/pharmacology, Hydrolysis, Microbial Sensitivity Tests, Moxalactam/*antagonists & inhibitors/pharmacology, Spectrophotometry, Ultraviolet, beta-Lactamases/*pharmacology
Pathogenicity3888103Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.Sutter VL, Emmerman J, Randall E, Zabransky RJ, Birk RJAntimicrob Agents Chemother10.1128/AAC.27.3.4241985Agar, Bacteria, Anaerobic/*drug effects, Microbial Sensitivity Tests, Microbiological Techniques, Moxalactam/*pharmacology
Pathogenicity3972999Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum.Mangels JI, Lindberg LHJ Clin Microbiol10.1128/jcm.21.2.269-272.19851985Bacteria, Anaerobic/*drug effects, Humans, Microbial Sensitivity Tests/*methods, Quality Control, Tetracycline/pharmacology
Pathogenicity6222065Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms.Zabransky RJ, Randall E, Sutter VL, Birk RJ, Westenfelder G, Emmerman J, Ghoneim ATJ Clin Microbiol10.1128/jcm.17.4.711-714.19831983Anaerobiosis, Bacteria/*drug effects, Cefoperazone, Cephalosporins/*pharmacology, Microbial Sensitivity Tests
Phylogeny7603469Synthesis and evaluation of a non-radioactive gene probe for the detection of C.perfringens alpha toxin.Schlapp T, Blaha I, Bauerfeind R, Wieler LH, Schoepe H, Weiss R, Baljer GMol Cell Probes10.1016/s0890-8508(95)80034-41995Bacillus cereus/classification, Bacterial Toxins/*analysis/genetics, Base Sequence, *Calcium-Binding Proteins, Chromosomes, Bacterial, Clostridium/classification/genetics, Clostridium perfringens/classification/genetics/*isolation & purification, DNA Primers/*chemical synthesis, Genes, Bacterial, Humans, Listeria monocytogenes/classification, Molecular Sequence Data, Nucleic Acid Hybridization, Staphylococcus aureus/classification, *Type C PhospholipasesPathogenicity
Metabolism7927785Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis.Ninomiya M, Matsushita O, Minami J, Sakamoto H, Nakano M, Okabe AInfect Immun10.1128/iai.62.11.5032-5039.19941994Animals, Bacillus subtilis, Bacterial Toxins/metabolism/*toxicity, *Calcium-Binding Proteins, Clostridium Infections/pathology/*physiopathology, Clostridium perfringens/*pathogenicity, Erythrocyte Count, Gas Gangrene/physiopathology, Hemolysin Proteins, Macrophages, Peritoneal/microbiology, Male, Mice, Platelet Count, Transformation, Genetic, Type C Phospholipases/metabolismPathogenicity
Phylogeny812355616S ribosomal DNA sequences of anaerobic cocci and proposal of Ruminococcus hansenii comb. nov. and Ruminococcus productus comb. nov.Ezaki T, Li N, Hashimoto Y, Miura H, Yamamoto HInt J Syst Bacteriol10.1099/00207713-44-1-1301994Anaerobiosis, Base Sequence, DNA, Bacterial/*chemistry, DNA, Ribosomal/*chemistry, Molecular Sequence Data, Peptococcaceae/*classification/*genetics, RNA, Ribosomal, 16S/*geneticsGenetics
Genetics8423073Comparison of the alpha-toxin genes of Clostridium perfringens type A and C strains: evidence for extragenic regulation of transcription.Katayama S, Matsushita O, Minami J, Mizobuchi S, Okabe AInfect Immun10.1128/iai.61.2.457-463.19931993Amino Acid Sequence, Bacterial Toxins/*genetics, Base Sequence, *Calcium-Binding Proteins, Clostridium perfringens/enzymology/*genetics/pathogenicity, Escherichia coli/genetics, Gene Expression Regulation, *Genes, Bacterial, Molecular Sequence Data, RNA, Messenger/analysis, *Transcription, Genetic, Type C Phospholipases/*geneticsPathogenicity
Enzymology8561916Diversity in the properties of two sialidase isoenzymes produced by Clostridium perfringens spp.Roggentin P, Kleineidam RG, Schauer RBiol Chem Hoppe Seyler10.1515/bchm3.1995.376.9.5691995Chromatography, Gel, Clostridium perfringens/*enzymology, Electrophoresis, Polyacrylamide Gel, Hydrogen-Ion Concentration, Hydrolysis, Isoelectric Focusing, Isoenzymes/chemistry/*metabolism, Kinetics, Molecular Weight, Neuraminidase/chemistry/*metabolism, Recombinant Proteins/biosynthesis, Substrate Specificity, TemperatureMetabolism
Pathogenicity8581165Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals.Ginter A, Williamson ED, Dessy F, Coppe P, Bullifent H, Howells A, Titball RWMicrobiology (Reading)10.1099/13500872-142-1-1911996Animals, Antibodies, Bacterial, Antibodies, Monoclonal, Antibody Specificity, Bacterial Toxins/*genetics/immunology/therapeutic use/toxicity, Bacterial Vaccines/*therapeutic use, Base Sequence, *Calcium-Binding Proteins, Cattle, Clostridium Infections/*prevention & control, Clostridium perfringens/genetics/*pathogenicity, Epitope Mapping, Female, *Genetic Variation, Humans, Intestinal Diseases/microbiology, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Peptide Fragments/immunology, Sequence Analysis, DNA, Soft Tissue Infections/microbiology, Species Specificity, Type C Phospholipases/analysis, Vaccines, Synthetic/*therapeutic use, VirulenceGenetics
Metabolism8867610Characterization of a toxin-deficient Clostridium perfringens strain, KZ1340.Shimizu T, Ohtani K, Ba-Thein W, Inui S, Nakamura S, Hayashi HMicrobiol Immunol10.1111/j.1348-0421.1996.tb03329.x1996Bacterial Toxins/*genetics/metabolism, *Calcium-Binding Proteins, Clostridium perfringens/*genetics/isolation & purification/metabolism, *Genes, Bacterial, Hemolysin Proteins, Microbial Collagenase/*genetics/metabolism, Plasmids, Transcription, Genetic, Transformation, Genetic, *Type C PhospholipasesPathogenicity
Phylogeny8880985Improved isolation of Clostridium perfringens from foal faeces.Netherwood T, Chanter N, Mumford JARes Vet Sci10.1016/s0034-5288(96)90090-91996Animals, Bacteriological Techniques, Clostridium Infections/diagnosis/*veterinary, Clostridium perfringens/*isolation & purification/physiology, Diarrhea/microbiology/*veterinary, Feces/microbiology, *Horse Diseases, Horses, Spores, BacterialEnzymology
Genetics9053381Collagenase gene (colA) is located in the 3'-flanking region of the perfringolysin O (pfoA) locus in Clostridium perfringens.Ohtani K, Bando M, Swe T, Banu S, Oe M, Hayashi H, Shimizu TFEMS Microbiol Lett10.1111/j.1574-6968.1997.tb10186.x1997Amino Acid Sequence, Bacterial Toxins/*genetics, Base Sequence, Chromosome Mapping, Clostridium perfringens/*enzymology/*genetics/pathogenicity, Collagenases/*genetics, DNA Primers/genetics, *Genes, Bacterial, Hemolysin Proteins, Molecular Sequence Data, Open Reading Frames, Virulence/genetics, beta-Galactosidase/geneticsPathogenicity
Phylogeny9241799Evaluation of the synergistic haemolysis (CAMP-like) test in the identification of motile, mesophilic Aeromonas species.Gubash SMZentralbl Bakteriol10.1016/s0934-8840(97)80073-41997Aeromonas/*classification/*isolation & purification, Aeromonas hydrophila/isolation & purification, Animals, Bacterial Toxins/immunology, *Bacterial Typing Techniques, Clostridium perfringens/immunology, Erythrocytes/immunology, Hemolysin Proteins, *Hemolysis, Sheep, *Sphingomyelin Phosphodiesterase, Staphylococcus aureus/immunologyEnzymology
Phylogeny10089527Crystallization and preliminary X-ray diffraction studies of alpha-toxin from two different strains (NCTC8237 and CER89L43) of Clostridium perfringens.Basak AK, Howells A, Eaton JT, Moss DS, Naylor CE, Miller J, Titball RWActa Crystallogr D Biol Crystallogr10.1107/s09074449980051861998Bacterial Toxins/*chemistry/isolation & purification, *Calcium-Binding Proteins, Clostridium perfringens/*chemistry/classification, Crystallization, Crystallography, X-Ray, Escherichia coli, Protein Conformation, Recombinant Fusion Proteins/chemistry/isolation & purification, Species Specificity, Type C Phospholipases/*chemistry/isolation & purificationEnzymology
Enzymology10585141A Clostridium perfringens hem gene cluster contains a cysG(B) homologue that is involved in cobalamin biosynthesis.Koyama M, Katayama S, Kaji M, Taniguchi Y, Matsushita O, Minami J, Morita S, Okabe AMicrobiol Immunol10.1111/j.1348-0421.1999.tb03355.x1999Base Sequence, Cloning, Molecular, Clostridium perfringens/*genetics/growth & development, DNA, Bacterial, *Genes, Bacterial, Methyltransferases/*genetics, Molecular Sequence Data, *Multigene Family, Mutagenesis, Open Reading Frames, Sequence Analysis, DNA, Sequence Homology, Amino Acid, Vitamin B 12/*biosynthesisGenetics
Cultivation10716567An effective lacticin biopreservative in fresh pork sausage.Scannell AG, Ross RP, Hill C, Arendt EKJ Food Prot10.4315/0362-028x-63.3.3702000Animals, Bacterial Proteins/pharmacology, Bacteriocins/*pharmacology, Clostridium perfringens/growth & development, Culture Media, Food Handling, *Food Preservation, Food Preservatives/pharmacology, Lactococcus lactis/*metabolism, Listeria/growth & development, Meat Products/*microbiology, Salmonella/growth & development, SwineMetabolism
Pathogenicity11297853Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel.Gadhi CA, Hatier R, Mory F, Marchal L, Weber M, Benharref A, Jana M, Lozniewski AJ Ethnopharmacol10.1016/s0378-8741(01)00185-42001Anti-Bacterial Agents/*pharmacology, Chloroform/chemistry, Clostridium perfringens/*drug effects/ultrastructure, Enterococcus faecalis/*drug effects/ultrastructure, Magnoliopsida/*chemistry, Microbial Sensitivity Tests, Microscopy, Electron, Plant Extracts/*pharmacology
Pathogenicity11938715In vitro effect of intracanal medicaments on strict anaerobes by means of the broth dilution method.Rosa OP, Torres SA, Ferreira CM, Ferreira FBPesqui Odontol Bras10.1590/s1517-749120020001000062002Bacteria, Anaerobic/*drug effects, Indicator Dilution Techniques, Reproducibility of Results, Root Canal Therapy/*methods, Therapeutic Irrigation
Pathogenicity12238802Activity of endodontic antibacterial agents against selected anaerobic bacteria.Ferreira CM, da Silva Rosa OP, Torres SA, Ferreira FB, Bernardinelli NBraz Dent J10.1590/s0103-644020020002000082002Bacteria, Anaerobic/*drug effects, Bacteroides fragilis/drug effects, Calcium Hydroxide/pharmacology, Camphor/pharmacology, Castor Oil/pharmacology, Chlorhexidine/*analogs & derivatives/pharmacology, Chlorophenols/pharmacology, Clostridium perfringens/drug effects, Culture Media, Detergents/pharmacology, Disinfectants/*pharmacology, Drug Combinations, Fusobacterium nucleatum/drug effects, Humans, Microbial Sensitivity Tests, Prevotella/drug effects, Root Canal Irrigants/*pharmacology, SpectrophotometryCultivation
Pathogenicity12650667Growth inhibition of intestinal bacteria and mutagenicity of 2-, 3-, 4-aminobiphenyls, benzidine, and biphenyl.Chung KT, Adris PToxicol In Vitro10.1016/s0887-2333(02)00131-52003Aminobiphenyl Compounds/*toxicity, Benzidines/*toxicity, Biphenyl Compounds/*toxicity, Gram-Negative Bacteria/drug effects/growth & development, Gram-Positive Bacteria/drug effects/growth & development, Humans, Intestines/*microbiology, Mutagenicity Tests, Mutagens/*toxicity
Cultivation15960756Susceptibility of Clostridium perfringens to C-C fatty acids.Skrivanova E, Marounek M, Dlouha G, Kanka JLett Appl Microbiol10.1111/j.1472-765X.2005.01709.x2005Clostridium Infections/prevention & control/veterinary, Clostridium perfringens/*drug effects/growth & development/ultrastructure, Culture Media, Fatty Acids/administration & dosage/*pharmacology, Food Additives/administration & dosage, Glucose, Hydrogen-Ion Concentration, Lauric Acids/pharmacology, Microbial Sensitivity Tests, Microscopy, Electron, TransmissionPathogenicity
Metabolism16085801Inhibition of Clostridium perfringens by a novel strain of Bacillus subtilis isolated from the gastrointestinal tracts of healthy chickens.Teo AY, Tan HMAppl Environ Microbiol10.1128/AEM.71.8.4185-4190.20052005Animals, *Antibiosis, Bacillus subtilis/classification/growth & development/*metabolism, Bacteriocins/chemistry/metabolism/*pharmacology, Chickens/*microbiology, Clostridium perfringens/*drug effects/growth & development, Culture Media, Gastrointestinal Tract/*microbiology, Hydrogen-Ion Concentration, Microbial Sensitivity Tests/methods, TemperatureCultivation
Enzymology16511172Cloning, recombinant production, crystallization and preliminary X-ray diffraction studies of a family 84 glycoside hydrolase from Clostridium perfringens.Ficko-Blean E, Boraston ABActa Crystallogr Sect F Struct Biol Cryst Commun10.1107/S17443091050240122005Catalysis, Cloning, Molecular, Clostridium perfringens/*enzymology/genetics, Crystallization, Glycoside Hydrolases/*chemistry/genetics, Recombinant Proteins/chemistry, X-Ray DiffractionBiotechnology
Genetics16825665Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens.Myers GS, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, Ren Q, Varga J, Awad MM, Brinkac LM, Daugherty SC, Haft DH, Dodson RJ, Madupu R, Nelson WC, Rosovitz MJ, Sullivan SA, Khouri H, Dimitrov GI, Watkins KL, Mulligan S, Benton J, Radune D, Fisher DJ, Atkins HS, Hiscox T, Jost BH, Billington SJ, Songer JG, McClane BA, Titball RW, Rood JI, Melville SB, Paulsen ITGenome Res10.1101/gr.52381062006Bacterial Toxins, Base Sequence, Clostridium perfringens/*genetics, DNA, Bacterial, *Genome, Bacterial, Molecular Sequence Data, Polymerase Chain ReactionPathogenicity
Metabolism17189979Detection of fibronectin-binding proteins in Clostridium perfringens.Katayama S, Nozu N, Yokoyama M, Hitsumoto YActa Med Okayama10.18926/AMO/307202006Carrier Proteins/*metabolism, Clostridium perfringens/*metabolism, Fibronectins/*metabolism, Humans, Protein BindingPathogenicity
Pathogenicity17981974Carbon catabolite repression of type IV pilus-dependent gliding motility in the anaerobic pathogen Clostridium perfringens.Mendez M, Huang IH, Ohtani K, Grau R, Shimizu T, Sarker MRJ Bacteriol10.1128/JB.01407-072007Anaerobiosis, Animals, Bacterial Proteins/genetics, Chemotaxis/genetics/physiology, Cloning, Molecular, Clostridium perfringens/drug effects/genetics/*pathogenicity/*physiology, DNA Primers, DNA-Binding Proteins/genetics, Fimbriae, Bacterial/*physiology, Gene Deletion, Genetic Complementation Test, Glucose/pharmacology, Glucuronidase/genetics/metabolism, Humans, Plasmids, Repressor Proteins/geneticsEnzymology
Enzymology18183385Identification of galacto-N-biose phosphorylase from Clostridium perfringens ATCC13124.Nakajima M, Nihira T, Nishimoto M, Kitaoka MAppl Microbiol Biotechnol10.1007/s00253-007-1319-82008Bacterial Proteins/genetics/metabolism, Base Sequence, Bifidobacterium/enzymology, Cloning, Molecular, Clostridium perfringens/*enzymology/metabolism, Codon, Initiator/analysis, Enzyme Stability, Galactose/*metabolism, Humans, Kinetics, Phosphorylases/chemistry/*genetics/isolation & purification/*metabolism, Phosphorylation, Recombinant Proteins/genetics/metabolism, Substrate SpecificityMetabolism
Proteome19000325Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies.Alam SI, Bansod S, Singh LBMC Microbiol10.1186/1471-2180-8-1942008Animals, Antibodies, Bacterial/immunology, Bacterial Proteins/*immunology, Bacterial Vaccines/*immunology, Clostridium perfringens/*immunology, Clostridium tetani/*immunology, Cross Reactions, Female, Immunization, Mice, Mice, Inbred BALB C, Proteome/immunology, Proteomics, Tetanus/immunology
Metabolism19292998Characterization of two putative fibronectin-binding proteins of Clostridium perfringens.Katayama S, Nozu N, Okuda M, Hirota S, Yamasaki T, Hitsumoto YAnaerobe10.1016/j.anaerobe.2009.03.0012009Bacterial Proteins/genetics/*metabolism, Cloning, Molecular, Clostridium perfringens/genetics/growth & development/isolation & purification/*metabolism, Enzyme-Linked Immunosorbent Assay, Fibronectins/*metabolism, Gas Gangrene/microbiology, Gene Expression Regulation, Bacterial, Humans, Polymerase Chain Reaction, Protein Binding, Recombinant Proteins/genetics/metabolismEnzymology
Metabolism19664283Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins.Alam SI, Bansod S, Kumar RB, Sengupta N, Singh LBMC Microbiol10.1186/1471-2180-9-1622009Animals, Bacterial Outer Membrane Proteins/*metabolism, Clostridium perfringens/*metabolism, Computational Biology, Culture Media, Female, Lyases/metabolism, Mass Spectrometry, Mice, Mice, Inbred BALB C, Ornithine Carbamoyltransferase/metabolism, Proteome/*metabolism, ProteomicsCultivation
Pathogenicity20193771Virulence for chickens of Clostridium perfringens isolated from poultry and other sources.Cooper KK, Theoret JR, Stewart BA, Trinh HT, Glock RD, Songer JGAnaerobe10.1016/j.anaerobe.2010.02.0062010Animals, Bacterial Toxins/*metabolism, Calcium-Binding Proteins/*metabolism, Cattle, Chickens, Clostridium Infections/microbiology/*veterinary, Clostridium perfringens/isolation & purification/*pathogenicity, Enteritis/microbiology/*veterinary, Humans, Poultry, Poultry Diseases/*microbiology, Species Specificity, Swine, Type C Phospholipases/*metabolism, VirulenceMetabolism
Enzymology20605988Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains.Sengupta N, Alam SI, Kumar B, Kumar RB, Gautam V, Kumar S, Singh LInfect Immun10.1128/IAI.00374-102010Animals, Bacterial Proteins/*analysis/immunology, Clostridium perfringens/*chemistry/classification/pathogenicity, Electrophoresis, Gel, Two-Dimensional, Female, Mice, Mice, Inbred BALB C, Ornithine Carbamoyltransferase/immunology, Proteomics/*methods, VirulencePhylogeny
Pathogenicity20944240Comparison of a nontoxic variant of Clostridium perfringens alpha-toxin with the toxic wild-type strain.Vachieri SG, Clark GC, Alape-Giron A, Flores-Diaz M, Justin N, Naylor CE, Titball RW, Basak AKActa Crystallogr D Biol Crystallogr10.1107/S090744491003369X2010Animals, Apoptosis/drug effects/genetics, Bacterial Toxins/*chemistry/genetics/metabolism/toxicity, Calcium-Binding Proteins/*chemistry/genetics/metabolism/toxicity, Catalytic Domain/genetics, Cattle, Cell Line, Cell Membrane/metabolism, Clostridium perfringens/*pathogenicity, Creatine Kinase/blood, Crystallization, Endothelial Cells/*drug effects/pathology, Host-Pathogen Interactions, Humans, Mice, Mice, Inbred Strains, Mutant Proteins/*chemistry/genetics/metabolism/toxicity, Phospholipids/*metabolism, Protein Binding, Protein Conformation, Substrate Specificity/genetics, Type C Phospholipases/*chemistry/genetics/metabolism/toxicityMetabolism
Enzymology21085950Lytic enzyme discovery through multigenomic sequence analysis in Clostridium perfringens.Schmitz JE, Ossiprandi MC, Rumah KR, Fischetti VAAppl Microbiol Biotechnol10.1007/s00253-010-2982-82010Amino Acid Sequence, Bacteriophages/*enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/*genetics/virology, Cluster Analysis, Computational Biology/*methods, Endopeptidases/*genetics/isolation & purification/metabolism, Enzyme Stability, Gene Expression, *Genome, Bacterial, Hydrogen-Ion Concentration, Molecular Sequence Data, Phylogeny, Recombinant Proteins/chemistry/genetics/isolation & purification/metabolism, Sequence Analysis, Sequence Homology, Amino Acid, TemperaturePhylogeny
Metabolism21905105Structural analysis of CPF_2247, a novel alpha-amylase from Clostridium perfringens.Ficko-Blean E, Stuart CP, Boraston ABProteins10.1002/prot.231162011Amino Acid Sequence, Bacterial Proteins/*chemistry/genetics/metabolism, Clostridium perfringens/*enzymology, Crystallography, X-Ray, Molecular Sequence Data, Protein Conformation, Protein Structure, Secondary, Protein Structure, Tertiary, Sequence Homology, Amino Acid, alpha-Amylases/*chemistry/genetics/*metabolismGenetics
22062270Use of gamma-irradiation to reduce Clostridium perfringens on ready-to-eat bovine tripe.Parry-Hanson A, Hall A, Minnaar A, Buys EMMeat Sci10.1016/j.meatsci.2007.06.0102007
Pathogenicity23452396Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.Park S, Park M, Rafii FBMC Microbiol10.1186/1471-2180-13-502013Anti-Bacterial Agents/*pharmacology, Bacterial Toxins/*metabolism, Clostridium perfringens/drug effects/*genetics/*metabolism, *Drug Resistance, Bacterial, Fluoroquinolones/*pharmacology, Microarray Analysis, Real-Time Polymerase Chain Reaction, Selection, Genetic, *TranscriptomeMetabolism
Pathogenicity23668605A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.Nagahama M, Oda M, Kobayashi K, Ochi S, Takagishi T, Shibutani M, Sakurai JMicrobiol Immunol10.1111/1348-0421.120362013Animals, Antibodies, Bacterial/blood, Antibodies, Neutralizing/blood, Antitoxins/blood, Bacterial Toxins/genetics/*immunology, Bacterial Vaccines/administration & dosage/genetics/*immunology, Calcium-Binding Proteins/genetics/*immunology, Clostridium Infections/immunology/*prevention & control, Clostridium perfringens/*immunology, Disease Models, Animal, Female, Mice, Mice, Inbred BALB C, Neutralization Tests, Recombinant Proteins/genetics/immunology, Survival Analysis, Type C Phospholipases/genetics/*immunology, Vaccines, Synthetic/administration & dosage/genetics/immunology
Pathogenicity23789809Effect of fluoroquinolone resistance selection on the fitness of three strains of Clostridium perfringens.Park M, Sutherland JB, Kim JN, Rafii FMicrob Drug Resist10.1089/mdr.2013.00562013Anti-Bacterial Agents/*pharmacology, Ciprofloxacin/*pharmacology, Clostridium perfringens/*drug effects/genetics/growth & development, Drug Resistance, Bacterial/genetics, Fluoroquinolones/*pharmacology, Gatifloxacin, Genetic Fitness/*drug effects, Microbial Sensitivity Tests, Microbial Viability/drug effects, Mutation, Norfloxacin/*pharmacology
Pathogenicity24083511Growth-Inhibiting and morphostructural effects of constituents identified in Asarum heterotropoides root on human intestinal bacteria.Perumalsamy H, Jung MY, Hong SM, Ahn YJBMC Complement Altern Med10.1186/1472-6882-13-2452013Asarum/*chemistry, Bacteria/*drug effects, Cell Shape/drug effects, Gastrointestinal Tract/drug effects/*microbiology, Humans, Microbial Sensitivity Tests, Microbiota/*drug effects, Plant Extracts/chemistry/*pharmacology, Plant Roots/chemistry
Pathogenicity24215704Inhibition of Clostridium perfringens growth by potassium lactate during an extended cooling of cooked uncured ground turkey breasts.Kennedy KM, Milkowski AL, Glass KAJ Food Prot10.4315/0362-028X.JFP-13-1062013Animals, Clostridium perfringens/drug effects/growth & development/physiology, Cold Temperature, Colony Count, Microbial, Dose-Response Relationship, Drug, Food Contamination/analysis/prevention & control, Food Handling/methods, Food Microbiology, Food Preservation/*methods, Food Preservatives/*pharmacology, Humans, Poultry Products/*microbiology, Sodium Lactate/pharmacology, Turkeys, United StatesBiotechnology
Enzymology26238688Comparative analysis of extractable proteins from Clostridium perfringens type A and type C strains showing varying degree of virulence.Dwivedi P, Alam SI, Kumar O, Kumar RBAnaerobe10.1016/j.anaerobe.2015.07.0062015Animals, Bacterial Proteins/*analysis/isolation & purification, Clostridium Infections/microbiology, Clostridium perfringens/*chemistry/pathogenicity, Disease Models, Animal, Electrophoresis, Gel, Two-Dimensional, Mass Spectrometry, Mice, Proteome/*analysis/isolation & purification, Survival Analysis, Virulence, Virulence Factors/*analysis/isolation & purificationPhylogeny
Biotechnology26492174Changes in microbial community during biohydrogen production using gamma irradiated sludge as inoculum.Yin Y, Wang JBioresour Technol10.1016/j.biortech.2015.10.0272015*Biofuels, *Gamma Rays, Hydrogen/*metabolism, *Microbial Consortia/genetics/radiation effects, Sewage/*microbiologyMetabolism
Genetics26528533Identification of a Bacteria-Specific Binding Protein from the Sequenced Bacterial Genome.Kong M, Ryu SJ Microbiol Biotechnol10.4014/jmb.1510.100562016Amino Acid Sequence, Bacterial Proteins/chemistry/genetics/*metabolism, Carrier Proteins/chemistry/genetics/*metabolism, Clostridium perfringens/chemistry/genetics/*metabolism, *Genome, Bacterial, Molecular Sequence Data, Protein Binding, Protein Structure, Tertiary, Sequence Alignment/*methodsMetabolism
Enzymology26663202Cloning, characterization, and production of three alpha-L-fucosidases from Clostridium perfringens ATCC 13124.Fan S, Zhang H, Chen X, Lu L, Xu L, Xiao MJ Basic Microbiol10.1002/jobm.2015005822015Animals, Cloning, Molecular, Clostridium perfringens/*enzymology/*genetics, Enzyme Activation, Escherichia coli/genetics, Fucose/metabolism, Gastric Mucins/metabolism, Glutamic Acid/metabolism, Mutagenesis, Site-Directed, Polysaccharides/metabolism, Substrate Specificity, Swine, alpha-L-Fucosidase/*biosynthesis/*geneticsMetabolism
26761495Screening of Bacteriocin-producing Enterococcus faecalis Strains for Antagonistic Activities against Clostridium perfringens.Han SK, Shin MS, Park HE, Kim SY, Lee WKKorean J Food Sci Anim Resour10.5851/kosfa.2014.34.5.6142014
Metabolism27038508The Details of Glycolipid Glycan Hydrolysis by the Structural Analysis of a Family 123 Glycoside Hydrolase from Clostridium perfringens.Noach I, Pluvinage B, Laurie C, Abe KT, Alteen MG, Vocadlo DJ, Boraston ABJ Mol Biol10.1016/j.jmb.2016.03.0202016Catalysis, Catalytic Domain/physiology, Clostridium perfringens/*metabolism, Galactose/metabolism, Glycolipids/*metabolism, Glycoside Hydrolases/*metabolism, Hydrolysis, beta-N-Acetyl-Galactosaminidase/metabolism
Pathogenicity27060276Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.Zhou YF, Yu Y, Sun J, Tao MT, Zhou WJ, Li X, Liao XP, Liu YHAnaerobe10.1016/j.anaerobe.2016.04.0052016Administration, Oral, Animals, Anti-Bacterial Agents/blood/*pharmacokinetics/pharmacology, Cecum/drug effects/microbiology, Clostridium Infections/blood/*drug therapy/microbiology, Clostridium perfringens/*drug effects/growth & development, Diterpenes/blood/pharmacokinetics/pharmacology, Drug Administration Schedule, Female, Half-Life, Injections, Intravenous, Intestine, Small/drug effects/microbiology, Male, Microbial Sensitivity Tests, RabbitsEnzymology
Metabolism27353489Putative function of hypothetical proteins expressed by Clostridium perfringens type A strains and their protective efficacy in mouse model.Alam SI, Dwivedi PInfect Genet Evol10.1016/j.meegid.2016.06.0402016Animals, Bacterial Proteins/*genetics/*immunology/metabolism, Cloning, Molecular, Clostridium perfringens/genetics/*pathogenicity, Disease Models, Animal, Escherichia coli/genetics, Female, Gas Gangrene/immunology, Mice, Inbred BALB C, Phylogeny, Recombinant Proteins/genetics/immunology/metabolismEnzymology
Enzymology27422836Efficient and Regioselective Synthesis of beta-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating beta-N-Acetylhexosaminidase from Bifidobacterium bifidum.Chen X, Xu L, Jin L, Sun B, Gu G, Lu L, Xiao MAppl Environ Microbiol10.1128/AEM.01325-162016Acetylgalactosamine/*metabolism, Acetylglucosamine/*metabolism, Bacteroides fragilis/enzymology/genetics, Bifidobacterium bifidum/*enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Enzyme Stability, Escherichia coli/genetics/metabolism, Gene Expression, Hydrogen-Ion Concentration, Kinetics, Lactose/*metabolism, Molecular Docking Simulation, Recombinant Proteins/chemistry/genetics/isolation & purification/metabolism, Temperature, beta-N-Acetylhexosaminidases/chemistry/genetics/isolation & purification/*metabolismMetabolism
Stress28058047Effect of Trehalose and Trehalose Transport on the Tolerance of Clostridium perfringens to Environmental Stress in a Wild Type Strain and Its Fluoroquinolone-Resistant Mutant.Park M, Mitchell WJ, Rafii FInt J Microbiol10.1155/2016/48297162016
Enzymology28185856Exposure to beta-lactams results in the alteration of penicillin-binding proteins in Clostridium perfringens.Park M, Rafii FAnaerobe10.1016/j.anaerobe.2017.02.0042017Animals, Anti-Bacterial Agents/*pharmacology, Cattle, Chickens, Clostridium Infections/microbiology/veterinary, Clostridium perfringens/*drug effects/*enzymology/isolation & purification, DNA Mutational Analysis, *Mutation, Missense, Penicillin-Binding Proteins/*genetics, Selection, Genetic, *beta-Lactam Resistance, beta-Lactams/*pharmacologyPhylogeny
Pathogenicity28213749Effect of continuous sub-culturing on infectivity of Clostridium perfringens ATCC13124 in mouse gas gangrene model.Kumar RB, Alam SIFolia Microbiol (Praha)10.1007/s12223-017-0503-12017Animals, Bacterial Proteins/genetics/metabolism, Clostridium perfringens/genetics/growth & development/*physiology, Disease Models, Animal, Gas Gangrene/*microbiology, Host-Pathogen Interactions, Humans, Mice, Mice, Inbred BALB CMetabolism
Metabolism28628892Structural characterization of wall and lipidated polysaccharides from Clostridium perfringens ATCC 13124.Vinogradov E, Aubry A, Logan SMCarbohydr Res10.1016/j.carres.2017.06.0032017Animals, Cell Wall/*chemistry, Clostridium perfringens/*chemistry/*cytology, *Lipid Metabolism, Lipopolysaccharides/chemistry, Polysaccharides/*chemistry/immunology/*metabolism, Rabbits, Teichoic Acids/chemistry
Enzymology29678922Enzymatic Synthesis of 6'-Sialyllactose, a Dominant Sialylated Human Milk Oligosaccharide, by a Novel exo-alpha-Sialidase from Bacteroides fragilis NCTC9343.Guo L, Chen X, Xu L, Xiao M, Lu LAppl Environ Microbiol10.1128/AEM.00071-182018Bacteroides fragilis/*enzymology/*genetics, Bifidobacterium bifidum/enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Escherichia coli/genetics, Gene Expression Regulation, Bacterial, Humans, Hydrogen-Ion Concentration, Infant Formula, Lactose/*analogs & derivatives/biosynthesis/metabolism, Milk, Human/*chemistry, Models, Molecular, Molecular Weight, Neuraminidase/*genetics/isolation & purification/*metabolism, Oligosaccharides/*metabolism, Protein Domains, Recombinant Proteins, Sequence Alignment, Sequence Analysis, Sialic Acids/metabolism, Substrate Specificity, Temperature, Time FactorsMetabolism
29725227Inhibition of Clostridium perfringens using Bacteriophages and Bacteriocin Producing Strains.Heo S, Kim MG, Kwon M, Lee HS, Kim GBKorean J Food Sci Anim Resour10.5851/kosfa.2018.38.1.882018
Biotechnology30637638Evaluation of Lactobacillus plantarum encapsulated with Eleutherine americana oligosaccharide extract as food additive in yoghurt.Phoem AN, Mayiding A, Saedeh F, Permpoonpattana PBraz J Microbiol10.1007/s42770-018-0017-22018Food Additives/*chemistry, Food Microbiology/*methods, Iridaceae/*chemistry, Lactobacillus plantarum/*chemistry/growth & development, Microbial Viability, Oligosaccharides/*chemistry, Plant Extracts/*chemistry, Probiotics/*chemistry, Yogurt/*analysis/microbiology
Pathogenicity30669805[A study on clinical application of a novel reagent detecting toxigenic strains of Clostridium difficile].Wang SM, Wang ZYZhonghua Yi Xue Za Zhi10.3760/cma.j.issn.0376-2491.2018.48.0132018Bacterial Toxins, *Clostridioides difficile, *Clostridium Infections, Feces, Humans, Polymerase Chain Reaction
31333591Galleria mellonella Infection Model Identifies Both High and Low Lethality of Clostridium perfringens Toxigenic Strains and Their Response to Antimicrobials.Kay S, Edwards J, Brown J, Dixon RFront Microbiol10.3389/fmicb.2019.012812019
Phylogeny31683584Capsular Polysaccharide Is a Receptor of a Clostridium perfringens Bacteriophage CPS1.Ha E, Chun J, Kim M, Ryu SViruses10.3390/v111110022019Bacterial Capsules/chemistry/genetics, Bacterial Proteins/genetics, *Bacteriophages/genetics/isolation & purification, Carbohydrate Epimerases/genetics, Clostridium perfringens/genetics/*virology, Genes, Bacterial, Genome, Viral, Phylogeny, *Podoviridae/classification/genetics/isolation & purification/ultrastructure, Polysaccharides, Bacterial/*genetics, Receptors, Virus/*genetics, UDPglucose 4-Epimerase/geneticsEnzymology
Pathogenicity32088319beta-Lactam resistance development affects binding of penicillin-binding proteins (PBPs) of Clostridium perfringens to the fluorescent penicillin, BOCILLIN FL.Park M, Sutherland JB, Rafii FAnaerobe10.1016/j.anaerobe.2020.1021792020Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Clostridium Infections/*diagnosis/*microbiology, Clostridium perfringens/drug effects/*genetics, Gene Expression Regulation, Bacterial, Humans, Penicillin-Binding Proteins/*genetics, Penicillins/pharmacology, Real-Time Polymerase Chain Reaction, *beta-Lactam Resistance
Phylogeny32097777Antibiotic resistance, genome analysis and further safe traits of Clostridium perfringens ICVB082; a strain capable of producing an inhibitory compound directed only against a closely related pathogenic strain.Vieco-Saiz N, Belguesmia Y, Vachee A, Le Marechal C, Salvat G, Drider DAnaerobe10.1016/j.anaerobe.2020.1021772020Animals, Anti-Bacterial Agents/*pharmacology, Antibiosis, Bacterial Toxins/genetics, Clostridium Infections/*veterinary, Clostridium perfringens/*drug effects/*genetics/pathogenicity, *Drug Resistance, Bacterial, Drug Resistance, Multiple, Bacterial, *Genome, Bacterial, Hemolysis, Phylogeny, Poultry Diseases/microbiology, RNA, Ribosomal, 16S, Virulence, Virulence FactorsPathogenicity
Phylogeny32388703Biodiversity and Phylogenetic Relationships of Novel Bacteriocinogenic Strains Isolated from Animal's Droppings at the Zoological Garden of Lille, France.Eveno M, Salouhi A, Belguesmia Y, Bazinet L, Gancel F, Fliss I, Drider DProbiotics Antimicrob Proteins10.1007/s12602-020-09657-42021Animals, Animals, Zoo/*microbiology, *Bacteria/classification/genetics/isolation & purification/metabolism, *Bacteriocins/biosynthesis/genetics, *Biodiversity, Feces/*microbiology, France, *PhylogenyEnzymology
Phylogeny33451155Dual Inhibition of Salmonella enterica and Clostridium perfringens by New Probiotic Candidates Isolated from Chicken Intestinal Mucosa.Lone A, Mottawea W, Ait Chait Y, Hammami RMicroorganisms10.3390/microorganisms90101662021
Pathogenicity33734645In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50.Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SSKlin Lab Diagn10.51620/0869-2084-2021-66-2-110-1142021Anti-Bacterial Agents, *Bacterial Infections, *Bacteriology, Child, Humans, Laboratories, Microbial Sensitivity Tests, Nutrients, Quality Control

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
428Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 756)https://www.dsmz.de/collection/catalogue/details/culture/DSM-756
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
42056Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/15204
44424Curators of the CCUGCulture Collection University of Gothenburg (CCUG) (CCUG 1795)https://www.ccug.se/strain?id=1795
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68367Automatically annotated from API 20A
68380Automatically annotated from API rID32A